[Matrine effects on JM cells by inhibiting proliferation and inducing apoptosis]

Ji-liang Feng1, Gao-sheng Huang, Yong-qing Zhang

  • 1Molecular Oncology Laboratory, Department of Pathology, Fourth Military Medical University, Xi'an 710032, Shanxi, China. jilangfeng@hotmail.com

Abstract

Insights

Matrine treatment induces apoptosis and inhibits proliferation in JM cells by repressing DNA synthesis and arresting the cell cycle at the G1 phase. These findings highlight matrine

Area of Science:

  • Pharmacology
  • Cell Biology
  • Biochemistry

Background:

  • Matrine is a natural alkaloid with potential therapeutic properties.
  • Understanding its effects on specific cell lines is crucial for drug development.

Purpose of the Study:

  • To investigate the effects of matrine on the JM cell strain.
  • To elucidate the mechanisms underlying matrine's action on cell proliferation and survival.

Main Methods:

  • Morphological analysis using light, fluorescence, and electron microscopy.
  • Cell cycle analysis via flow cytometry.
  • DNA fragmentation detection using gel electrophoresis.

Main Results:

  • Matrine treatment led to typical apoptosis features in JM cells.
  • Flow cytometry revealed sub-G1 peaks and increased G1 phase arrest with higher matrine concentrations.
  • DNA laddering, indicative of apoptosis, was observed at higher matrine doses.

Conclusions:

  • Matrine inhibits JM cell proliferation by repressing DNA synthesis and inducing G1 phase arrest.
  • Matrine effectively induces apoptosis in JM cells.
  • These results suggest matrine's potential as an anti-proliferative and apoptotic agent.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...